Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.

Mäenpää N, Tiainen L, Martikainen J, Tanner M, Jukkola A, Bärlund M

Open source

DOI
10.1371/journal.pone.0353941
Published
2026
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0353941,
  title = {Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.},
  author = {Mäenpää N and Tiainen L and Martikainen J and Tanner M and Jukkola A and Bärlund M},
  year = {2026},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0353941},
  url = {https://doi.org/10.1371/journal.pone.0353941}
}

RIS

TY  - JOUR
TI  - Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.
AU  - Mäenpää N
AU  - Tiainen L
AU  - Martikainen J
AU  - Tanner M
AU  - Jukkola A
AU  - Bärlund M
PY  - 2026
JO  - PloS one
DO  - 10.1371/journal.pone.0353941
UR  - https://doi.org/10.1371/journal.pone.0353941
ER  - 

APA

N, M., L, T., J, M., M, T., A, J., & M, B. (2026). Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.. PloS one. https://doi.org/10.1371/journal.pone.0353941

Source records